Pregabalin add‐on therapy using a flexible, optimized dose schedule in refractory partial epilepsies: A double‐blind, randomized, placebo‐controlled, multicenter trial

Abstract

PGB was effective and easily tolerable as add-on treatment in an Asian population with refractory partial-onset seizures.